Epitope peptides derived from vascular endothelial growth factor receptor 1 and vaccines containing these peptides
AssigneeOncotherapy Science, Inc.
InventorsHideaki Tahara, Takuya Tsunoda, Masabumi Shibuya, Shuichi Nakatsuru
Life of this patent
Estimating the term…
Abstract
The present invention provides immunogenic peptides comprising the amino acid sequence of SEQ ID NO: 1, 2, 13, 32, and peptides comprising the above-mentioned amino acid sequences in which 1, 2, or several amino acids are substituted or added, and having cytotoxic T cell inducibility, and also provides drugs for treating or preventing tumors comprising these peptides. The peptides of this invention can be used as vaccines.
Claims22
An isolated peptide of less than about 15 amino acids comprising the amino acid sequence of SEQ ID NO:
- 1, 2, 13.
An isolated peptide having cytotoxic T cell inducibility, wherein the peptide comprises the amino acid sequence of SEQ ID NO:
- 1, 2, 13, wherein zero, 1, 2, or several amino acids are substituted or added.
An isolated peptide of less than about 15 amino acids comprising the amino acid sequence of SEQ ID NO:
- 25.
An isolated peptide having cytotoxic T cell inducibility, wherein the peptide comprises the amino acid sequence of SEQ ID NO:
- 25, wherein zero 1, 2, or several amino acids are substituted or added.
-21. (canceled)
Dependencies are inferred from the claim text.